Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
GEHC Stock Forecast 2026-2027
$65.18
Current Price
$29.65B
Market Cap
Buy 12
Hold 6
Sell 0
Wall St Analyst Ratings
Distance to GEHC Price Targets
+50.4%
To High Target of $98.00
+22.7%
To Median Target of $80.00
-0.3%
To Low Target of $65.00
GEHC Price Momentum
+0.8%
1 Week Change
+7.3%
1 Month Change
-9.8%
1 Year Change
-20.5%
Year-to-Date Change
-27.4%
From 52W High of $89.77
+10.9%
From 52W Low of $58.75
📊 TOP ANALYST CALLS
Did GEHC Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if GE HealthCare is one of their latest high-conviction picks.
Latest GEHC Stock Price Targets & Analyst Predictions
Based on our analysis of 2 Wall Street analysts, GEHC has a bullish consensus with a median price target of $80.00 (ranging from $65.00 to $98.00). The overall analyst rating is Strong Buy (8.3/10). Currently trading at $65.18, the median forecast implies a 22.7% upside. This outlook is supported by 12 Buy, 6 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
GEHC Analyst Ratings
12
Buy
6
Hold
0
Sell
GEHC Price Target Range
Low
$65.00
Average
$80.00
High
$98.00
Current: $65.18
Latest GEHC Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for GEHC.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| May 21, 2026 | UBS | Graham Doyle | Neutral | Upgrade | $69.00 |
| Apr 30, 2026 | JP Morgan | Neutral | Maintains | $N/A | |
| Apr 30, 2026 | Citigroup | Neutral | Maintains | $N/A | |
| Apr 30, 2026 | Goldman Sachs | Neutral | Downgrade | $N/A | |
| Apr 30, 2026 | Barclays | Equal-Weight | Maintains | $N/A | |
| Apr 30, 2026 | Evercore ISI Group | Outperform | Maintains | $N/A | |
| Apr 30, 2026 | Wells Fargo | Overweight | Maintains | $N/A | |
| Apr 29, 2026 | BTIG | Buy | Maintains | $N/A | |
| Apr 21, 2026 | BTIG | Buy | Reiterates | $N/A | |
| Apr 17, 2026 | Piper Sandler | Overweight | Maintains | $N/A | |
| Apr 13, 2026 | Mizuho | Outperform | Maintains | $N/A | |
| Apr 9, 2026 | Goldman Sachs | Buy | Maintains | $N/A | |
| Apr 6, 2026 | Evercore ISI Group | Outperform | Maintains | $N/A | |
| Mar 26, 2026 | Piper Sandler | Overweight | Maintains | $N/A | |
| Mar 19, 2026 | BTIG | Buy | Reiterates | $N/A | |
| Mar 11, 2026 | Citigroup | Neutral | Maintains | $N/A | |
| Feb 9, 2026 | BTIG | Buy | Reiterates | $N/A | |
| Feb 6, 2026 | Barclays | Equal-Weight | Maintains | $N/A | |
| Feb 5, 2026 | Stifel | Buy | Maintains | $N/A | |
| Feb 5, 2026 | Evercore ISI Group | Outperform | Maintains | $N/A |
GE HealthCare Technologies Inc. (GEHC) Competitors
The following stocks are similar to GE HealthCare based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
GEHC
GE HealthCare
mkt cap
29.65B
GE HealthCare Technologies Inc. (GEHC) Financial Data
GE HealthCare Technologies Inc. has a market capitalization of $29.65B with a P/E ratio of 15.6x. The company generates $20.98B in trailing twelve-month revenue with a 9.1% profit margin.
Revenue growth is +7.4% quarter-over-quarter, while maintaining an operating margin of +11.1% and return on equity of +19.5%.
Valuation Metrics
Market Cap
$29.65B
Enterprise Value
$38.20B
P/E Ratio
15.6x
PEG Ratio
-0.5x
Price/Sales
1.4x
Growth & Margins
Revenue Growth (YoY)
+7.4%
Gross Margin
+38.5%
Operating Margin
+11.1%
Net Margin
+9.1%
EPS Growth
-31.0%
Financial Health
Cash/Price Ratio
+7.6%
Current Ratio
1.2x
Debt/Equity
97.1x
ROE
+19.5%
ROA
+5.2%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
GE HealthCare Technologies Inc. (GEHC) Business Model
About GE HealthCare Technologies Inc.
What They Do
Develops medical imaging and diagnostic technologies.
Business Model
The company generates revenue by developing and manufacturing a wide range of medical technology products, including imaging systems, ultrasound equipment, and patient monitoring tools. It serves various healthcare sectors, including hospitals and research institutions, by providing both products and digital solutions that enhance diagnostic and treatment processes.
Additional Information
GE HealthCare Technologies Inc. is structured into four key segments: Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics. With its headquarters in Chicago, Illinois, the company is integral to advancing healthcare technologies and improving operational efficiencies in medical settings.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
54,000
CEO
Mr. Peter J. Arduini
Country
United States
IPO Year
2023
Website
www.gehealthcare.comGE HealthCare Technologies Inc. (GEHC) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
QuidelOrtho (QDEL) Up 24.1% Since Last Earnings Report: Can It Continue?
QuidelOrtho (QDEL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Jun 04, 2026
By Zacks Equity Research
Realtime BLOG
Latest News
Quick Summary
GE HealthCare will present its enterprise imaging solutions at the SIIM 2026 Annual Meeting, addressing challenges in medical imaging due to rising volumes, complexity, and staffing shortages.
Why It Matters
GE HealthCare's focus on enterprise imaging solutions highlights its potential for growth in a market facing rising demand and staffing challenges, signaling opportunities for revenue increase and competitive advantage.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
GE Healthcare has received FDA clearance for its AI-powered radiation planning software, which includes new clinical models and a streamlined process for future updates.
Why It Matters
GEHC's FDA clearance for AI software enhances its product portfolio, potentially increasing market share and revenue, signaling strong growth prospects for investors.
Source: Zacks Investment Research
Market Sentiment:
Positive
GE HealthCare Technologies Inc. (GEHC) Presents at Jefferies Global Healthcare Conference 2026 Transcript
12 days ago
Quick Summary
GE HealthCare Technologies Inc. participated in the Jefferies Global Healthcare Conference 2026, presenting insights relevant to investors in the healthcare sector.
Why It Matters
GE HealthCare's presentation at a major healthcare conference can signal company strategy, product developments, and market positioning, influencing investor sentiment and stock performance.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
GE HealthCare (Nasdaq: GEHC) has received FDA 510(k) clearance for its AI-enabled auto-contouring software, MIM Contour ProtégéAI+™ 2.0, enhancing efficiency in radiation oncology treatment planning.
Why It Matters
GE HealthCare's FDA clearance for new AI software enhances efficiency in radiation oncology, potentially increasing market share and profitability, which could positively impact stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
GE HealthCare is set to showcase new technologies and AI workflows at the 2026 SNMMI Annual Meeting, addressing the growing demand for nuclear medicine and improving operational efficiency.
Why It Matters
Growing demand for theranostics and radiopharmaceuticals signals a bullish trend for GE HealthCare, potentially increasing revenue and market share in the healthcare sector.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
GE HealthCare Technologies is reportedly exploring undervalued investment opportunities in the market.
Why It Matters
GE HealthCare Technologies' strategy of bottom fishing suggests potential undervaluation, which could present buying opportunities for investors looking for growth in the healthcare sector.
Source: Seeking Alpha
Market Sentiment:
Neutral
Frequently Asked Questions About GEHC Stock
What is GE HealthCare Technologies Inc.'s (GEHC) stock forecast for 2026?
Based on our analysis of 2 Wall Street analysts, GE HealthCare Technologies Inc. (GEHC) has a median price target of $80.00. The highest price target is $98.00 and the lowest is $65.00.
Is GEHC stock a good investment in 2026?
According to current analyst ratings, GEHC has 12 Buy ratings, 6 Hold ratings, and 0 Sell ratings. The stock is currently trading at $65.18. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for GEHC stock?
Wall Street analysts predict GEHC stock could reach $80.00 in the next 12 months. This represents a 22.7% increase from the current price of $65.18. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is GE HealthCare Technologies Inc.'s business model?
The company generates revenue by developing and manufacturing a wide range of medical technology products, including imaging systems, ultrasound equipment, and patient monitoring tools. It serves various healthcare sectors, including hospitals and research institutions, by providing both products and digital solutions that enhance diagnostic and treatment processes.
What is the highest forecasted price for GEHC GE HealthCare Technologies Inc.?
The highest price target for GEHC is $98.00 from at , which represents a 50.4% increase from the current price of $65.18.
What is the lowest forecasted price for GEHC GE HealthCare Technologies Inc.?
The lowest price target for GEHC is $65.00 from at , which represents a -0.3% decrease from the current price of $65.18.
What is the overall GEHC consensus from analysts for GE HealthCare Technologies Inc.?
The overall analyst consensus for GEHC is bullish. Out of 2 Wall Street analysts, 12 rate it as Buy, 6 as Hold, and 0 as Sell, with a median price target of $80.00.
How accurate are GEHC stock price projections?
Stock price projections, including those for GE HealthCare Technologies Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: June 15, 2026 10:05 AM UTC